Health Care Equipment

Koninklijke Philips Elect

Philips Consortium Signs 8-Year Contract with Stockholm for Remote Home Hospital Care

RBC Capital Analyst Maintains Hold Rating on Royal Philips with a Price Target of €25

Koninklijke Philips Elect released FY2026 Q1 earnings on May 6 Pre-Market (EST), actual revenue USD 4.475 B (forecast USD 4.452 B), actual EPS USD 0.1818

Philips Reports First Quarter Financial Data

Philips' Smart Fit TorsoCardiac 1.5T MR Coil Receives FDA 510(k) and CE Clearances

Barclays Analyst Maintains Buy Rating and Sets Target Price for Royal Philips

Koninklijke Philips Elect to release FY2026 Q1 earnings on May 6 Pre-Market EST, forecast revenue USD 4.532 B

Philips showcases three-year forward-looking solutions at CMEF

Deutsche Bank Downgrades Philips Target Price

Philips SmartHeart Cardiac MRI Planning Software Receives FDA Approval

Royal Philips Launches Snuggle Pediatric MRI Coil

Koninklijke Philips Elect released FY2025 Q4 earnings on February 10, 2026 (EST), with actual revenue of USD 5.988 B (forecast USD 5.902 B), actual EPS USD 0.4743

Koninklijke Philips Elect released FY2025 Annual Earnings on February 10, 2026 (EST), with actual revenue of USD 20.55 B (forecast USD 20.87 B) and actual EPS of USD 1.0667 (forecast USD 0.7655)

Philips Reports Q4 Profit and Outlines Future Growth Outlook

Koninklijke Philips Elect to release FY2025 Q4 earnings on February 9, 2026 (EST), forecast revenue USD 5.852 B

Emergency Care Holdings Launches Heartstream as an Independent Company

Philips' Emergency Care Business Transformed into ECH Platform Company

Barclays analyst maintains buy rating on Royal Philips

Egyptian Ministry of Health and Philips Collaborate on Feasibility Study for Local CT Scanner Production

Jefferies analyst maintains hold rating on Royal Philips

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Royal Philips N.V. (PHG.US) 2024 Third Quarter Earnings Conference Call

Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026 | PHG Stock News

StockTitan

Koninklijke Philips N.V.

Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026 | PHG Stock News

Philips has launched SmartIQ, a new coronary imaging technology that significantly reduces X-ray radiation exposure by over 50% while enhancing image quality. This innovation addresses the longstanding challenge of balancing image clarity and radiation dose in coronary procedures. SmartIQ will be showcased at EuroPCR 2026, with initial clinical studies indicating improved image quality and lower radiation levels. The technology is CE-marked and available in Europe, although not yet approved for use in the U.S.

iShares US Medical Devices

Health Care Select Sector SPDR

SPDR S&P Health Equip

Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures | PHG Stock News

Philips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm | PHG Stock News

Philips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm | PHG Stock News

RYLPF

RBC Capital analyst Natalia Webster has maintained a Hold rating on Koninklijke Philips N.V. with a price target of €25.00. Webster has an average return of -7.0% and a 26.09% success rate, covering the Healthcare sector. J.P. Morgan also issued a Hold rating, while DZ BANK AG maintained a Buy rating on the company.

Tip Ranks

SPDR S&P Health

iShares US Healthcare Providers

ROYAL BANK OF CANADA

Siemens Healthineers AG

SANDOZ GROUP AG SPON ADS EACH REP 1 COM SHS

JPMorgan Chase

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

RBC Capital Sticks to Its Hold Rating for Koninklijke Philips N.V. (0LNG)

DZ BANK AG has maintained a Buy rating on Koninklijke Philips N.V. (0LNG), with shares closing at €22.91. Analyst Aristotelis Moutopoulos has a price target of €26.91, indicating a 17.46% upside. The consensus among analysts is a Moderate Buy, with Barclays also supporting a Buy rating and a price target of €29.50.

Barclays

Koninklijke Philips N.V. (0LNG) Gets a Buy from DZ BANK AG

Philips shareholders approved all proposals at the AGM 2026, including the appointment of John DeFord to the Supervisory Board and the re-appointment of Roy Jakobs as President/CEO. The board expressed confidence in Jakobs' leadership for the company's strategic phase. The AGM also discharged board members and acknowledged Marc Harrison for his contributions. Philips aims to enhance execution, innovation, and performance while delivering sustainable value to stakeholders.

Philips shareholders approve all proposals at the AGM 2026 | PHG Stock News

Barclays analyst Hassan Al-Wakeel has reaffirmed a Buy rating on Koninklijke Philips N.V. with a price target of €29.50. Al-Wakeel has an average return of -2.4% and a success rate of 42.18%. UBS's Graham Doyle also issued a Buy rating for the company recently, while J.P. Morgan maintained a Hold rating.

UBS Group AG

Barclays Remains a Buy on Koninklijke Philips N.V. (0LNG)

J.P. Morgan analyst David Adlington has maintained a Hold rating on Koninklijke Philips N.V. (0LNG) with a price target of €22.60. Adlington has an average return of -6.4% and a success rate of 38.87%. Jefferies analyst Julien Dormois also issued a Hold rating for the company, while UBS maintained a Buy rating on the same day.

Koninklijke Philips N.V. (0LNG) Receives a Hold from J.P. Morgan

Philips reported a 6% increase in order intake and a 4% rise in comparable sales for Q1 2026, with adjusted earnings per share of 27 cents, surpassing expectations. Despite a challenging macro environment, the healthcare technology company showed growth across all segments, particularly in Personal Health. The stock rose 2.72% to $27.17, although technical indicators suggest mixed near-term momentum. Philips maintains its 2026 outlook with expected sales growth of 3%-4.5% and an adjusted EBITA margin of 12.5%-13.0%.

benzinga_article

BioNTech SE

Micron Tech

Philips Reports Strong Order Intake Despite Uncertain Macro Environment

Koninklijke Philips Elect(PHG.US)

Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026 | PHG Stock News

Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures | PHG Stock News

Philips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm | PHG Stock News

RBC Capital Sticks to Its Hold Rating for Koninklijke Philips N.V. (0LNG)

Koninklijke Philips N.V. (0LNG) Gets a Buy from DZ BANK AG

Philips shareholders approve all proposals at the AGM 2026 | PHG Stock News

Barclays Remains a Buy on Koninklijke Philips N.V. (0LNG)

Koninklijke Philips N.V. (0LNG) Receives a Hold from J.P. Morgan

Philips Reports Strong Order Intake Despite Uncertain Macro Environment